Standard oral glutathione capsules (non-liposomal) have less than 10% bioavailability and wont produce measurable symptom relief regardless of dose
When glutathione levels drop, the immune system effectively "loses its brakes," allowing for the overproduction of pro-inflammatory cytokines like Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-)
The molecule is small enough to cross the epidermal barrier to some degree, but reaching fibroblasts in the mid-to-deep dermis where the structural work happens requires either injection or a delivery mechanism that bypasses the barrier
That is a 60% decline in the molecule responsible for stimulating collagen synthesis, coordinating tissue repair, and maintaining skin architecture
Because of its potency, IV glutathione must always be administered under medical supervision, following proper assessment, dosing protocols, and safety standards
The role of oxidative stress in cardiac disease: from physiological response to injury factor